MedTrace Logo

Ischemic Heart Disease in Male With Prostate Adenocarcinoma

NCT03474835 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-03-23

No results posted yet for this study

Summary

The purpose of the study: to increase the efficiency of diagnosis, treatment and prediction of the course of coronary heart disease in patients with adenocarcinoma of the prostate gland, depending on the hormonal status by determining the cardiovascular risk factors, factors of angiogenesis, structural and functional state of the heart, coronary vessels, kidney damage and their pharmacological correction.

Conditions

  • Ischemic Heart Disease
  • Prostate Adenocarcinoma

Interventions

DIAGNOSTIC_TEST

ISCHEMIC HEART DISEASE diagnostic

ISCHEMIC HEART DISEASE diagnostic

Sponsors & Collaborators

  • Dnipropetrovsk State Medical Academy

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-15
Primary Completion
2018-04-15
Completion
2019-01-15

Countries

  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03474835 on ClinicalTrials.gov